According to the National Health Council, nearly 40% of the adult population in the US is diagnosed with at least one chronic condition, such as diabetes, asthma, and hypertension. The annual cost burden associated with chronic diseases in the US is around USD 3.8 trillion. This has prompted stakeholders to develop devices that enable self-administration of drugs. Amongst the various self-injection devices, autoinjectors have steadily gained prominence, especially for the treatment of emergency...

Tissue injury and dysfunctioning commonly occurs in humans; however, not in all cases, the tissue regeneration capability of a human body is able to cope up with the damage caused. o improve on this aspect, additive manufacturing, specifically 3D bioprinting, is being explored in the tissue engineering domain. The 3D bioprinting technique employs bioinks (consisting of living cells and biomaterials) to fabricate complex anatomical structures (tissues, cartilages and organs), in a layer-by-layer...

The global monkeypox treatment market size is estimated to shrink from USD 86 million in 2026 to USD 4.8 million by 2035, representing a CAGR of (-)27.4% during the forecast period 2026 to 2035. In May 2022, multiple cases of the disease were reported in several non-endemic countries, thereby making monkeypox a disease of global concern. In fact, till date, over 71,000 cases of the disease have been reported, globally. In response to the monkeypox outbreak, active research and development effort...

The global blockchain in healthcare market valued at USD 78 million in 2025, is project to reach USD 96 million in 2026 and USD 641 million by 2035, representing a higher CAGR of 23.5% during the forecast period 2026 to 2035. In terms of type of blockchain, the private blockchain segment holds the highest share (~40%) of the market. With regards to type of end-user, the hospitals segment dominates the global market with 35% market share. In terms of geographical regions, Asia-Pacific captures th...

The 4D bioprinting market, valued at USD 31 million in 2025, is projected to grow to USD 40 million in 2026 and USD 684 million by 2035, representing a CAGR of 37.2% during the forecast period. Owing to the ongoing advancements in the 4D bio fabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of af...

The global exosome therapy market is estimated to grow from USD 32 million in 2029 to reach USD 382 million in 2035 and USD 1,405 million by 2040, representing a higher CAGR of 41.1% during the forecast period. In recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse indications, primarily owing to the various benefits offered by them, including target specificity, enhanced tissue regeneration, an...

Attempts to synthetically recreate the biological circuits in human body is a relatively new area of research within synthetic biology. Ever since the 2010s, the use of molecular

The at home testing kits market, valued at USD 18.21 billion in 2025, is projected to grow to USD 19.24 billion in 2026 and USD 31.15 billion by 2035, representing a CAGR of 5.5% during the forecast period. Since the approval of the first over-the-counter test kits in early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US...

The global handheld ultrasound scanners market is estimated to grow from USD 583 million in 2024 to USD 1,142 million by 2030, representing a CAGR of 12% during the forecast period. Point-of-care ultrasound or handheld ultrasound imaging devices emerged as a viable solution to empower clinicians with portable, mobile, and lightweight scanners for disease diagnosis. For instance, Butterfly IQ (an innovative handheld ultrasound scanner) is available at only 2% of the cost of a conventional ultraso...

The drug device combination products market, valued at USD 327 million in 2025, is projected to grow to USD 357 million in 2026 and USD 938 million by 2035, representing a CAGR of 11.3% during the forecast period. Combination products comprise of two or more FDA- regulated components that provide controlled release of the APIs. However, the development of drug-device combination products is a long-drawn-out process that not only requires novel technologies and processes but also a huge amount of...

Over the last 2 decades, gene editing concepts and genetic engineering have evolved significantly, with the development of a variety of versatile DNA modulation technologies, including clustered, regularly interspaced short palindromic repeats (CRISPR), zinc finger nucleases and transcription activator-like effector-based nucleases (TALENs). CRISPR / Cas system is a powerful tool with a wide array of applications in the field of disease treatment and diagnosis, and agriculture and biotechnology....

The global single use sensors market size, valued at USD 0.50 billion in 2025, is projected to reach USD 0.58 billion in 2026 and USD 1.92 billion by 2035, representing a CAGR of 14.2% during the forecast period. The biopharmaceutical industry is witnessing an upsurge due to the growing demand for advanced therapeutic drugs that target a broad range of diseases. Several blockbuster drugs, including monoclonal antibodies and cell and gene therapies, require highly controlled bioprocessing technol...

The global protein engineering market, valued at USD 0.85 billion in 2025, is projected to reach USD 0.96 billion in 2026 and USD 3.15 billion by 2035, with a 14.1% CAGR during the forecast period 2026 to 2035. Driven by the significance offered by protein-based medications, several pharmaceutical companies accelerated their research efforts towards development of novel medicines. It is worth highlighting here that more than 55 protein-based therapies have already been marketed for the treatm...

The tissue engineering market, valued at USD 4.6 billion in 2025, is projected to reach USD 4.9 billion in 2026 and USD 12.7 billion by 2035, with a 11.2% CAGR during the forecast period 2026 to 2035. Over the years, there has been an increase in accidental injuries and diseases that result in tissue or organ damage. According to a research report, nearly 6% of individuals are projected to be affected by chronics wounds across the globe. To address the concern, regenerative medicine and tissue e...

Microbiome refers to the diverse community of microorganisms that inhibit different environments in and on the human body (such as gut, respiratory tract, skin and urogenital tract). In fact, the human microbiome contains about 100 trillion microbes. However, the imbalances in microbiota, also known as dysbiosis, often results in negative health consequences including (but not limited to) anxiety, autism, cancer, diabetes, infectious diseases, inflammatory bowel diseases and obesity. In the abov...

The global in vitro ADME toxicology testing market, valued at USD 4.5 billion in 2025, is projected to reach USD 5.2 billion in 2026 and USD 6.0 billion by 2030, with a 3.9% CAGR during the forecast period 2026 to 2030. The need for improved therapeutic drugs to target a wide range of diseases has heightened the focus on ADME toxicology testing to ensure the efficiency and safety of medicines for human use. Currently, oncology disorders are likely to hold the largest share of the market and are...

The global precision medicine software market size, valued at USD 43 million in 2025, is projected to reach USD 81 million in 2026 and USD 324 million by 2032, representing a CAGR of 26.0% during the forecast period. Precision medicine software is a form of specialized computer applications or programs specifically designed to support the development of personalized treatment in healthcare. Personalized medicine refers to the tailored treatment approach that has been designed on the basis of the...

The oral proteins and peptides market, valued at USD 2.47 billion in 2025, is projected to grow to USD 3.26 billion in 2026 and USD 8.42 billion by 2032, representing a CAGR of 17.1% during the forecast period. The growth of the oral proteins and peptides market is mainly driven by the rising prevalence of chronic diseases such as diabetes, chronic idiopathic constipation, and others. These chronic diseases require daily dose of medicine, sometime multiple dose in a day. Owing to the large size...

The liposome manufacturing market, valued at USD 0.9 billion in 2025, is projected to grow to USD 1.0 billion in 2026 and USD 2.3 billion by 2035, representing a CAGR of 10.1% during the forecast period. Liposome manufacturing involves the production of liposomes, which are small artificial vesicles composed of lipid bilayers. These vesicles are capable of encapsulating drugs or other active molecules within their structure which allow targeted delivery to specific sites within the body. The mar...

The global safety syringe and safety needles market, valued at USD 6.80 billion in 2025, is projected to reach USD 6.90 billion in 2026 and USD 8.90 billion by 2035, representing a CAGR of 2.9% during the forecast period. Given the increasing incidence of needlestick injury among patients, there is a surge in the requirement of safety syringes and needles. Safety needles refer to syringes that are specifically designed to reduce the risk of needlestick injuries and enhance safety to prevent the...